Century Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.3% | -3.4% | +19.5% | -6.7% | -9.1% | -10.6% | -9.8% | -14.0% | -8.6% | +46.0% | -12.1% | |
| – | +1.9% | +12.9% | +1.8% | +1.2% | -5.8% | -12.6% | -5.6% | -14.0% | -12.3% | +15.1% | -10.3% | |
| – | -14.4% | -1.1% | -11.4% | +26.9% | +11.1% | -11.3% | +9.7% | -2.4% | +11.4% | -17.5% | -2.8% | |
| – | +1.9% | +11.2% | +2.3% | +0.9% | -4.5% | -12.8% | -5.6% | -14.8% | -11.8% | +15.1% | -11.2% | |
| – | -60.1% | – | – | -23.3% | +12.7% | -35.3% | -36.3% | -22.7% | +37.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -7.1% | – | – | – | – | – | – | – | |
| – | – | – | – | +1.5% | +1.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -1.3% | -3.0% | +13.9% | -0.7% | -0.6% | -60.8% | -0.5% | -8.6% | -5.3% | -4.6% | -11.6% | |
| – | -12.7% | -10.0% | +19.3% | +3.4% | +554.8% | -88.8% | +3.1% | +47.4% | -8.2% | -32.9% | +11.1% | |
| – | -25.8% | +46.4% | +65.4% | +2.6% | +29.6% | +0.2% | +0.2% | -22.9% | -11.9% | +22.8% | – | |
| – | -53.8% | +25.2% | -2.2% | -22.6% | +18.4% | +16.2% | -10.2% | -18.4% | +82.4% | -34.0% | +53.1% | |
| – | -15.7% | -3.7% | +24.9% | -11.9% | -17.5% | +49.0% | -12.7% | -16.0% | -9.9% | +66.6% | -12.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +4.0% | +31.8% | +3.2% | -7.1% | +9.5% | +0.2% | +0.3% | +0.1% | +0.0% | +137.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.